China's First Homegrown ALS Gene Therapy Achieves 69% Protein Reduction — Published in Nature Medicine
Beijing Tiantan Hospital's neurology team developed RAG-17, China's first domestically developed siRNA drug for ALS, which reduced toxic SOD1 protein by up to 69% in a Phase 1 trial — results published in Nature Medicine.














